# Overcome Biochemical Aspirin Resistance Through Cilostazol Combination

> **NCT00446641** · PHASE4 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 244 (actual)

## Conditions studied

- Cerebral Infarction

## Interventions

- **DRUG:** Cilostazol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00446641
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-06
- **Final completion:** 2008-07
- **Target enrollment:** 244 (ACTUAL)
- **Last updated:** 2010-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00446641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00446641, "Overcome Biochemical Aspirin Resistance Through Cilostazol Combination". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00446641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*